Templeton Emerging Markets Fund
EMF · NYSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | -$0 |
| % Growth | -58.1% | 205.5% | 111.2% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 78.7% | 100% | 74.7% | 103.8% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 419.4% | 100.2% | 169.3% | 100% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 416.9% | 98.8% | 169.3% | 100.5% |
| EPS Diluted | 3.36 | 1.86 | 1.02 | -5.21 |
| % Growth | 80.6% | 82.4% | 119.6% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |